NICE says yes to Hycamtin for small-cell lung cancer
This article was originally published in Scrip
Executive Summary
NICE, the National Institute for health and Clinical Excellence, is to publish on Wednesday final guidance recommending GlaxoSmithKline's Hycamtin (topotecan) for treating NHS patients in England and Wales with small-cell lung cancer.